STOCK TITAN

Tempus AI reported $1.3B in revenue and a $245.0M net loss for fiscal 2025. See the full TEM financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Tempus CEO Eric Lefkofsky will speak at Morgan Stanley’s 2026 Global Healthcare Conference, with the session streamed via live audio webcast.

(Moderate)
(Neutral)
Tags
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM) today announced that Founder and CEO Eric Lefkofsky will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 8:30 a.m. ET in New York City.

A live audio webcast of the conversation will be available here.

About Tempus

Tempus AI is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Tempus
hanah.heintzelman@tempus.com

Source: Tempus AI, Inc.